196 related articles for article (PubMed ID: 30223590)
1. HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
Klieser E; Urbas R; Swierczynski S; Stättner S; Primavesi F; Jäger T; Mayr C; Kiesslich T; Fazio PD; Helm K; Neureiter D
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223590
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic Regulations.
Klieser E; Illig R; Státtner S; Primavesi F; Jáger T; Swierczynski S; Kiesslich T; Kemmerling R; Bollmann C; Di Fazio P; Neureiter D
Anticancer Res; 2015 Nov; 35(11):6127-36. PubMed ID: 26504039
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.
Song YL; Yu R; Qiao XW; Bai CM; Lu CM; Xiao Y; Zhong DR; Chen J; Zhao YP; Zhang TP; Song TT; Gao HL; Wan YH; Shen L; Chen J; Lv B; Hao JJ; Zhang Y; Tang L; Chen YJ
Sci Rep; 2017 May; 7(1):2205. PubMed ID: 28526880
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
Wanek J; Gaisberger M; Beyreis M; Mayr C; Helm K; Primavesi F; Jäger T; Di Fazio P; Jakab M; Wagner A; Neureiter D; Kiesslich T
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321986
[TBL] [Abstract][Full Text] [Related]
7. Integrative microRNA-mRNA and protein-protein interaction analysis in pancreatic neuroendocrine tumors.
Zhou HQ; Chen QC; Qiu ZT; Tan WL; Mo CQ; Gao SW
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2842-52. PubMed ID: 27424984
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Damaskos C; Koutsounas I; Zizi-Serbetzoglou A; Tsoukalas N; Patsouris E; Kouraklis G; Theocharis S
BMC Gastroenterol; 2015 Oct; 15():148. PubMed ID: 26502922
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
10. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.
Swierczynski S; Klieser E; Illig R; Alinger-Scharinger B; Kiesslich T; Neureiter D
Expert Opin Biol Ther; 2015 May; 15(5):651-64. PubMed ID: 25766312
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
13. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
Mazzio EA; Soliman KF
Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
[TBL] [Abstract][Full Text] [Related]
14. Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
Yamana H; Kato K; Kobara H; Fujihara S; Fujita K; Namima D; Fujita N; Kobayashi K; Kamada H; Morishita A; Tsutsui K; Iwama H; Masaki T
Anticancer Res; 2020 Jan; 40(1):121-132. PubMed ID: 31892560
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms.
Grolmusz VK; Kövesdi A; Borks K; Igaz P; Patócs A
Eur J Endocrinol; 2018 Oct; 179(4):219-228. PubMed ID: 30299890
[TBL] [Abstract][Full Text] [Related]
16. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M
Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.
Gill P; Kim E; Chua TC; Clifton-Bligh RJ; Nahm CB; Mittal A; Gill AJ; Samra JS
Endocr Pathol; 2019 Jun; 30(2):128-133. PubMed ID: 30767148
[TBL] [Abstract][Full Text] [Related]
19. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
